FDA Contracts With Company to Use Aborted Fetal Remains in Research


In August of 2016 the National Institutes of Health announced it wanted to use public funds for research to create human-animal hybrids or “chimeras.” The goal was to inject human stem cells into modified animal embryos in hopes of discovering new cures or “growing” human organs for transplant patients.


At the time the news sounded like nothing less than something out of a supermarket tabloid. Two years later, however, we’ve learned the Food and Drug Administration is apparently contracting with a group in California to inject mice with tissue obtained from aborted babies.


In June the FDA announced it was awarding a contract to Advanced Bioscience Resources, Inc., “to acquire Tissue for Humanized Mice.”


The announcement went on to say “[Advanced Bioscience Resources, Inc.] is the only company that can provide the human fetal tissue needed to continue the ongoing research being led by the FDA. Fresh human tissues are required for implantation into severely immune-compromised mice to create chimeric animals that have a human immune system.”

In other words, Advanced Bioscience Resources will be providing the FDA with fetal tissue that it can use in research — and the fetal tissue almost certainly is being harvested from aborted babies.


8-10-18  2:06 p.m.  kawx.org